Effects of Tregalizumab on Allergen-induced Airway Responses and Airway Inflammation in Asthmatic Patients

NCT04673591 · clinicaltrials.gov ↗

PHASE2

Phase

COMPLETED

Status

42

Enrollment

INDUSTRY

Sponsor class

Conditions

Allergy to House Dust Mite
Allergic Asthma

Interventions

DRUG: Tregalizumab
OTHER: Placebo

Sponsor

T-Balance Therapeutics GmbH